Fucus vesiculosus / Phyllitis scolopendrium comp. Gocce per uso orale

国家: 瑞士

语言: 意大利文

来源: Swissmedic (Swiss Agency for Therapeutic Products)

有效成分:

adonis vernalis (HAB) D3, alchemilla vulgaris (HAB) D2, arnica montana (HAB) D3, carbo vegetabilis (HAB) D6, fucus vesiculosus (HAB) D2, hyssopus officinalis e herba rec. D2 (HAB 3a), nasturtium officinale (HAB) D2, phyllitis scolopendrium e herba rec. D2 (HAB 3a), phytolacca americana (HAB) D4

可用日期:

Regena AG

INN（国际名称）:

adonis vernalis (HAB) D3, alchemilla vulgaris (HAB) D2, arnica montana (HAB) D3, carbo vegetabilis (HAB) D6, fucus vesiculosus (HAB) D2, hyssopus officinalis e herba rec. D2 (HAB 3a), nasturtium officinale (HAB) D2, phyllitis scolopendrium e herba rec. D2 (HAB 3a), phytolacca americana (HAB) D4

药物剂型:

Gocce per uso orale

组成:

adonis vernalis (HAB) D3 0.11 ml, alchemilla vulgaris (HAB) D2 0.11 ml, arnica montana (HAB) D3 0.11 ml, carbo vegetabilis (HAB) D6 0.11 ml, fucus vesiculosus (HAB) D2 0.11 ml, hyssopus officinalis e herba rec. D2 (HAB 3a) 0.11 ml, nasturtium officinale (HAB) D2 0.11 ml, phyllitis scolopendrium e herba rec. D2 (HAB 3a) 0.11 ml, phytolacca americana (HAB) D4 0.11 ml, aqua purificata, ethanolum 96 per centum 0.39 g, ad solutionem pro 1 ml, corresp. 47 guttae, corresp. ethanolum 49 % V/V.

类:

D

治疗组:

Farmaci Omeopatici

治疗领域:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

授权状态:

zugelassen

授权日期:

2011-03-31